Bispectral Index as an Analgesia Monitoring in Severely Ill Patient: Effect of Remifentanyl
Recruitment status was: Recruiting
|Study Design:||Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Primary Purpose: Prevention
|Official Title:||Bispectral Index as an Analgesia Monitoring in Severely Ill Patient: Effect of Remifentanyl|
- BIS variation during bronchoalveolar lavage
- Systolic blood pressure, diastolic blood pressure, heart rate viation
|Study Start Date:||October 2004|
Pain is difficult to estimate in ICU because most of the patients are sedated. Bispectral index could be helpful in detecting this pain in ICU patients. Remifentanil is a morphinomimetic product with short half life that could be interesting for short nociceptive stimuli, as bronchoalveolar lavage.
The purpose of this study is to evaluate the impact of remifentanil infusion on bispectral index (BIS) variations during bronchoalveolar lavage.
It is a prospective, double blind study, versus placebo on 40 sedated and critically ill patients.
The hypothesis is that BIS can study analgesia in sedated patient.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00162591
|Surgical ICU Bichat Claude Bernard|
|Paris, France, 75018|
|Principal Investigator:||QUINTARD H Hervé, MD||Surgical ICU Bichat Claude Bernard (Paris, France)|